In vitro 3D model and miRNA drug delivery to target calcific aortic valve disease
© 2017 The Author(s). Calcific aortic valve disease (CAVD) is the most prevalent valvular heart disease in the Western population, claiming 17000 deaths per year in the United States and affecting 25% of people older than 65 years of age. Contrary to traditional belief, CAVD is not a passive, degene...
Main Authors: | van der Ven, Casper FT, Wu, Pin-Jou, Tibbitt, Mark W, van Mil, Alain, Sluijter, Joost PG, Langer, Robert, Aikawa, Elena |
---|---|
Other Authors: | Koch Institute for Integrative Cancer Research at MIT |
Format: | Article |
Language: | English |
Published: |
Portland Press Ltd.
2021
|
Online Access: | https://hdl.handle.net/1721.1/135754 |
Similar Items
-
Engineering a 3D-Bioprinted Model of Human Heart Valve Disease Using Nanoindentation-Based Biomechanics
by: van der Valk, Dewy C., et al.
Published: (2018) -
Standardization of Human Calcific Aortic Valve Disease in vitro Modeling Reveals Passage-Dependent Calcification
by: Shinji Goto, et al.
Published: (2019-04-01) -
Engineering a 3D-Bioprinted Model of Human Heart Valve Disease Using Nanoindentation-Based Biomechanics
by: Dewy C. van der Valk, et al.
Published: (2018-05-01) -
CircRNA/lncRNA–miRNA–mRNA network and gene landscape in calcific aortic valve disease
by: Yuqi Zheng, et al.
Published: (2023-07-01) -
Quantification of calcified particles in human valve tissue reveals asymmetry of calcific aortic valve disease development
by: Katsumi Yabusaki, et al.
Published: (2016-11-01)